NUTRIGENOMICS
Understand how your body responds to foods and nutrients
Explore
- Technology
- Our Products
- About Us
Explore
Did you know over 290,000 people die annually in China and USA due to adverse drug reactions? **
Our pharmacogenetics products provide answers to questions like this and more by analyzing your response to more than 100 FDA-approved medications. This information can be used by healthcare providers to optimize the choice and dosage of medications.
Pharmacogenomics is the combination of pharmacology (science of drugs) and genomics (the study of genes), which provides information about how your genetic profile affects your response to drugs. Pharmacogenomics could help prevent potential adverse reactions to drugs, which could range from wasted time and money to life-threatening events. There are a number of variations in your gene that influence the way you respond to drugs.
Most of these variations have to do with enzymes that metabolize one or more drugs. Some variations could indicate a strong chance that a particular medication will result in toxicity, while other variations could mean the effectiveness of a drug is vastly reduced. Choosing the right drug and dose based on genetic screening results could lead to significant improvements in treatment results.
With a simple saliva sample, iGenes can help you select the medication(s) and dose(s) that are best suited to your condition and genetic makeup. The report will identify the right medication, the proper dosage as well as medications that may be harmful for you across more than 100 FDA-approved medications. With this information, you can help inform your physician and/or pharmacist about the optimal medication and dosage based on your genes and prevent potential adverse reactions to drugs.
CARDIOVASCULAR
DIABETES
PSYCHIATRIC
PAIN
COMMONLY PRESCRIBED DRUGS
PAEDIATRICS
GERIATRICSLazarou J, Pomeranz, BH, Corey PN. Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies. JAMA. 1998 Apr; 279 (15):1200-1205.
Wu Z, Zhang X, Shen L, Xiong Y, Wu X, Huo R, Wei Z, Cai L, Qi G, Xu Q, Cui D. A systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland China–a basis for personalized therapy. PloS one. 2013 Oct 2;8(10):e71934.
